sacrosidase
| Brand name | Sucraid |
|---|---|
| Active ingredient | sacrosidase |
| Strength | 17,000IU/2ML (8,500IU/ML) |
| Dosage form | Solution For Oral |
| Route | Oral |
| Modality | Biologic |
| FDA approval | May 2022 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.